Fournier gangrene screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Fournier gangrene}} {{SCC}}; {{AE}} {{YK}}; {{JH}} ==Overview== ==References== {{Reflist|2}}" |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Fournier gangrene. | |||
== Screening == | |||
According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Fournier gangrene. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 17:42, 7 September 2017
|
Fournier gangrene Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fournier gangrene screening On the Web |
|
American Roentgen Ray Society Images of Fournier gangrene screening |
|
Risk calculators and risk factors for Fournier gangrene screening |
Steven C. Campbell, M.D., Ph.D.; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[1]; Jesus Rosario Hernandez, M.D. [2]
Overview
According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Fournier gangrene.
Screening
According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Fournier gangrene.